60° Pharmaceuticals

About 60° Pharmaceuticals

60° Pharmaceuticals (60P) was founded in 2010 with a mission to discover, develop, and distribute new medicines for treatment and prevention of tropical diseases. Our core business is delivering tropical disease drug research and development while providing an attractive return for investors. 60P has embraced an open innovation approach to reduce the time, cost, and risk needed to build a portfolio of drug discovery and development projects. We collaborate with leading research institutions in the United States, Australia, and Singapore to discover and develop medications for dengue fever and malaria prevention.
YEAR FOUNDED:
2010
LEADERSHIP:
CEO: Geoffrey Dow
CFO: Ty Miller
CMO: Bryan Smith
JOBS:
Please click here for 60° Pharmaceuticals job opportunities.